GlaxoSmithKline gains European marketing approval for kidney disease drug daprodustatProactive Investors • 03/01/22
Medicago and GSK Announce the Approval by Health Canada of COVIFENZ®, an Adjuvanted Plant-Based COVID-19 VaccineBusiness Wire • 02/24/22
GlaxoSmithKline and Sanofi plan to submit data from COVID-19 booster and Phase III trials for approvalProactive Investors • 02/23/22
Dow Jones Newswires: Sanofi, GSK to seek approval for Covid-19 vaccine after positive trial resultsMarket Watch • 02/23/22
GlaxoSmithKline says demerger of consumer healthcare company Haleon on track for mid-2022Proactive Investors • 02/23/22
GlaxoSmithKline goes with Haleon as new name of its Consumer Healthcare divisionProactive Investors • 02/22/22
Glaxo (GSK) Q4 Earnings Top Estimates, Xevudy Adds $1.1B in SalesZacks Investment Research • 02/10/22